Use of cookies by
Norton Rose Group
We use cookies to deliver our online services. Details and instructions on how to disable those cookies are set out here. By continuing to use this website you agree to our use of our cookies unless you have disabled them.

Health, pharmaceuticals and biotechnology

Our pharmaceutical and biotechnology group is an active participant in the pharmaceutical industry with a client portfolio that includes many local and international companies. We have played a key role in driving many industry issues including campaigning for the industry in respect of new legislation.

A hallmark of the industry is its heavy regulation, and understanding those regulations end to end and how the whole jigsaw fits together is one of our key strengths.

We know the pharmaceutical and biotechnology industries, the legal principles applicable and the practical issues and problems. We take a holistic view of these matters and understand the context in which they occur.

Our expert lawyers provide clients with advice on all aspects of the law as it applies to the pharmaceutical and biotechnology industries including regulatory requirements, intellectual property, technology transfer agreements, licensing, clinical trial agreements and trade practices. In addition, we advise in related areas such as venture capital.

We are heavily involved in new aspects such as those around stem cells, and make an active contribution to the many and various dialogues around ethical issues in this area.

Related contacts

Bernard Oshea

Bernard O'Shea

Partner

Melbourne

+61 3 8686 6573

The team
RSS feed